{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:13:12Z","timestamp":1777111992541,"version":"3.51.4"},"publisher-location":"Chichester, UK","reference-count":223,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000551","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:20:09Z","timestamp":1069366809000},"source":"Crossref","is-referenced-by-count":28,"title":["Ursodeoxycholic acid for primary biliary cirrhosis"],"prefix":"10.1002","author":[{"given":"C","family":"Gluud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,10,23]]},"reference":[{"key":"10.1002\/14651858.CD000551-BIB3|cit1","first-page":"1421","article-title":"A randomised controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) (AASLD Abstract)","volume":"8","author":"Hadziyannis","year":"1988","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB4|cit2","series-title":"XI International Bile Acid Meeting. Bile Acids as Therapeutic Agents - From Basic Science to Clinical Practice. Freiburg","first-page":"57","article-title":"Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: the third year of a controlled trial","author":"Hadziyannis","year":"1990"},{"key":"10.1002\/14651858.CD000551-BIB1|cit3","series-title":"Bile Acids as Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58","first-page":"287","article-title":"Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: the third year of a controlled trial","author":"Hadziyannis","year":"1991"},{"key":"10.1002\/14651858.CD000551-BIB2|cit4","first-page":"580","article-title":"A randomized controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) [abstract]","volume":"10","author":"Hadziyannis","year":"1989","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000551-BIB5|cit5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(00)80485-7","article-title":"Ursodeoxycholic-acid for primary biliary cirrhosis: final results of a 12-year prospective, randomised, controlled trial","volume":"32","author":"Papatheodoridis","year":"2000","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB8|cit6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0168-8278(01)81572-5","article-title":"Factors influencing histological progression of early primary biliary cirrhosis. Effect of ursodeoxycholic acid","volume":"34","author":"Pares","year":"2001","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB9|cit7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(01)81564-6","article-title":"Long-term ursodeoxycholic acid treatment delays progression of mild primary biliary cirrhosis","volume":"34","author":"Pares","year":"2001","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB6|cit8","unstructured":"Par\u00e9s A The Spanish Association for the Study of the Liver Personal communication 1998"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB7|cit9","first-page":"166","article-title":"Long-term treatment of primary biliary cirrhosis with ursodeoxycholic acid: results of a randomized, double-blind, placebo-controlled trial (abstract)","volume":"26","year":"1997","journal-title":"J Hepatol"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB15|cit10","first-page":"A1163","article-title":"Extended follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis (Abstract)","volume":"110","author":"Carithers","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB14|cit11","doi-asserted-by":"crossref","first-page":"175A","DOI":"10.1016\/0270-9139(93)92227-Q","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxcholic acid (UDCA) in primary biliary cirrhosis (AASLD Abstract)","volume":"18","author":"Combes","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB17|cit12","series-title":"Falk Symposium No. 68. XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel","first-page":"43","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC)","author":"Combes","year":"1992"},{"key":"10.1002\/14651858.CD000551-BIB12|cit13","series-title":"Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68","first-page":"289","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","author":"Combes","year":"1993"},{"key":"10.1002\/14651858.CD000551-BIB16|cit14","series-title":"Falk Symposium No. 80. XIII International Bile Acid Meeting. Bile Acids in Gastroenterology: Basic and Clinical Aspects. San Diego","first-page":"67","article-title":"The American multicenter primary biliary cirrhosis, Ursodiol versus placebo study group (PUPS) trial","author":"Combes","year":"1994"},{"key":"10.1002\/14651858.CD000551-BIB10|cit15","first-page":"759","article-title":"A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"22","author":"Combes","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB11|cit16","first-page":"91A","article-title":"Ursodeoxycholic acid therapy in patients with primary biliary cirrhosis [AASLD abstract]","volume":"14","author":"Combes","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB18|cit17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hep.510300315","article-title":"The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis","volume":"30","author":"Combes","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB13|cit18","first-page":"168A","article-title":"Does ursodeoxycholic acid improve survival in patients with primary biliary cirrhosis? Comparison of outcome in the US multicenter trial to expected survival using the Mayo Clinic prognostic model [AASLD abstract]","volume":"24","author":"Emond","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB19|cit19","first-page":"49","article-title":"Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid","volume":"30 Suppl 1","author":"G\u00fcld\u00fctuna","year":"1992","journal-title":"Z-Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB21|cit20","first-page":"299","article-title":"Ursodeoxycholic acid therapy in primary biliary cirrhosis","author":"Leuschner","year":"1993","journal-title":"Bile acids and the hepatobiliary system. From Basic Science to Clinical Practice. Falk Symposium 68"},{"key":"10.1002\/14651858.CD000551-BIB20|cit21","first-page":"A621","article-title":"Does ursodeoxycholic acid (UDCA) influence cell membrane architecture in patients with primary biliary cirrhosis (PBC)?","volume":"96","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB24|cit22","first-page":"133","article-title":"UDCA in der Behandlung der prim\u00e4ren bili\u00e4ren Zirrhose: Ergebnisse einer kontrollierten Studie","volume":"24","author":"Leuschner","year":"1989","journal-title":"Ergebnisse der Gastroenterologie"},{"key":"10.1002\/14651858.CD000551-BIB22|cit23","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial","volume":"97","author":"Leuschner","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB23|cit24","series-title":"Trends in Bile Acid Research. Falk Symposium 52","first-page":"355","article-title":"Ursodeoxycholic acid (UDCA) treatment of primary biliary cirrhosis: clinical and histological results of a controlled study","author":"Leuschner","year":"1989"},{"key":"10.1002\/14651858.CD000551-BIB25|cit25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3109\/00365529709000190","article-title":"Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study","volume":"32","author":"Eriksson","year":"1997","journal-title":"Scand-J-Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB29|cit26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00196579","article-title":"Ursodeoxycholic acid treatment lowers the serum levels of antibodies against pyrovate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis","volume":"74","author":"Kisand","year":"1996","journal-title":"J Mol Med"},{"key":"10.1002\/14651858.CD000551-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0270-9139(95)90046-2","article-title":"Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine","volume":"21","author":"Miettinen","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB28|cit28","first-page":"A954","article-title":"Improvement of serum noncholesterol sterols may indicate retarded progression of primary biliary cirrhosis (PBC) in a randomized placebo controlled two-year trial with colchicine and ursodeoxycholic acid (AASLD abstract)","volume":"104","author":"Miettinen","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB30|cit29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0168-8278(97)80293-0","article-title":"Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis","volume":"27","author":"Vuoristo","year":"1997","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB26|cit30","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB32|cit31","first-page":"151A","article-title":"A trial of ursodeoxycholic acid (UDCA) and colchicine in primary biliary cirrhosis (PBC) (AASLD abstract)","volume":"20","author":"Goddard","year":"1994","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB31|cit32","first-page":"A30","article-title":"Surrogate markers of response in a trial of ursodeoxycholic acid (UDCA) and colchicine in primary biliary cirrhosis (PBC)","volume":"36","author":"Goddard","year":"1995","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD000551-BIB51|cit33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","article-title":"Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid","volume":"19","author":"Angulo","year":"1999","journal-title":"Liver"},{"key":"10.1002\/14651858.CD000551-BIB39|cit34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(12)61815-1","article-title":"Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis [see comments]","volume":"69","author":"Balan","year":"1994","journal-title":"Mayo-Clin-Proc"},{"key":"10.1002\/14651858.CD000551-BIB44|cit35","doi-asserted-by":"crossref","first-page":"175A","DOI":"10.1016\/0270-9139(93)92228-R","article-title":"The effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirhosis (AASLD Abstract)","volume":"18","author":"Batts","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB34|cit36","first-page":"2314","article-title":"Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis","volume":"91","author":"Batts","year":"1996","journal-title":"Am-J-Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB42|cit37","first-page":"A732","article-title":"The effect of ursodeoxycholic acid compared to placebo on lumbar spine bone mineral density in patients with primary biliary cirrhosis","volume":"100","author":"Crippin","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB40|cit38","series-title":"Bile acids as therapeutic agents. From Basic Science to Clinical Practice. Falk Symposium 58","first-page":"271","article-title":"Beneficial effects of ursodeoxycholic acid in an open trial of patients with primary biliary cirrhosis","author":"Dickson","year":"1991"},{"key":"10.1002\/14651858.CD000551-BIB47|cit39","series-title":"Falk Symposium No. 68. XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel","first-page":"44","article-title":"Ursodiol (URSO) is effective therapy for patients with primary biliary cirrhosis (PBC)","author":"Dickson","year":"1992"},{"key":"10.1002\/14651858.CD000551-BIB41|cit40","series-title":"Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68","first-page":"292","article-title":"Ursodiol is effective therapy for patients with primary biliary cirrhosis","author":"Dickson","year":"1993"},{"key":"10.1002\/14651858.CD000551-BIB36|cit41","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/gut.36.6.935","article-title":"Characterisation of patients with a complete biochemical response to ursodeoxycholic acid","volume":"36","author":"Jorgensen","year":"1995","journal-title":"Gut"},{"issue":"4 (Part 2)","key":"10.1002\/14651858.CD000551-BIB50|cit42","doi-asserted-by":"crossref","first-page":"174 A","DOI":"10.1016\/0270-9139(93)92221-K","article-title":"Dissimilar patterns of serum and biliary bile acids in primary biliary cirrhosis (PBC) patients treated with ursodeoxycholic acid (UDCA)","volume":"18","author":"Lacerda","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB38|cit43","first-page":"1840","article-title":"The natural history of abdominal pain associated with primary biliary cirrhosis","volume":"89","author":"Laurin","year":"1994","journal-title":"Am-J-Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB35|cit44","first-page":"91A","article-title":"Ursodeoxycholic acid (UDCA) is beneficial therapy for patients with primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"16","author":"Lindor","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB37|cit45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis [see comments]","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB43|cit46","first-page":"389","article-title":"Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?","volume":"21","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB46|cit47","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1002\/14651858.CD000551-BIB49|cit48","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1572-0241.1998.00470.x","article-title":"Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"93","author":"Lindor","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB33|cit49","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1053\/gast.1996.v110.pm8613058","article-title":"Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis","volume":"110","author":"Lindor","year":"1996","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB45|cit50","doi-asserted-by":"crossref","first-page":"A1111","DOI":"10.1016\/0016-5085(95)28744-2","article-title":"Effects of ursodeoxycholic acid (UDCA) on survival in patients with primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"108","author":"Lindor","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB48|cit51","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1572-0241.1998.00287.x","article-title":"Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy","volume":"93","author":"Zukowski","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB52|cit52","doi-asserted-by":"crossref","first-page":"57I","DOI":"10.1016\/0270-9139(94)90396-4","article-title":"Does treatment with ursodeoxycholic acid (UDCA) really diminish cholesterol serum levels in primary biliary cirrhosis (PBC)? [IASL abstract]","volume":"19","author":"Mora","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB53|cit53","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0168-8278(05)80214-4","article-title":"Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC","volume":"17","author":"Battezzati","year":"1993","journal-title":"J-Hepatol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB56|cit54","first-page":"87","article-title":"Ursodeoxycholic acid (UDCA) for symptomatic primary biliary cirrhosis (PBC): a double-blind multicenter trial (EASL abstract)","volume":"9","year":"1989","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB54|cit55","series-title":"Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68","first-page":"310","article-title":"Long-term effect of the administration of ursodeocycholic acid alone or with colchicine in patients with primary biliary cirrhosis: a double-blind multicentre study","author":"Podda","year":"1993"},{"key":"10.1002\/14651858.CD000551-BIB55|cit56","first-page":"639","article-title":"Urodeoxycholic acid (UDCA) for symptomatic primary biliary cirrhosis (PBC): a double-blind multicenter trial [AASLD abstract]","volume":"10","author":"Podda","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB58|cit57","first-page":"222","article-title":"Effect of ursodiol on biliary bile acid composition and conjugation in patients with primary biliary cirrhosis","volume":"98","author":"Batta","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB57|cit58","first-page":"A617","article-title":"Ursodiol treatment of primary biliary cirrhosis","volume":"98","author":"O'Brian","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB61|cit59","first-page":"208","article-title":"Caution: not all patients with primary biliary cirrhosis may successfully be treated by ursodiol","author":"O'Brian","year":"1990","journal-title":"Second International Meeting on Pathochemistry, Pathophysiology and Pathomechanisms of the Biliary System and New Strategies for the Treatment of Hepato-Biliary Diseases. Bologna"},{"key":"10.1002\/14651858.CD000551-BIB60|cit60","first-page":"438","article-title":"Effect of oral ursodiol treatment on the predicted probability of mortality in primary biliary cirrhosis","volume":"12","author":"Senior","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB59|cit61","series-title":"Bile Acids as Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58","first-page":"273","article-title":"Mortality risk indices as outcome measures of the effectiveness of ursodeoxycholic acid treatment of cholestatic liver diseases","author":"Senior","year":"1991"},{"key":"10.1002\/14651858.CD000551-BIB62|cit62","first-page":"415","article-title":"No symptomatic or histological benefit from ursodeoxycholic acid treatment in PBC after 1 year. Controlled pilot study [IASL abstract]","volume":"12","author":"Myszor","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB63|cit63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1440-1746.1994.tb01237.x","article-title":"A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis","volume":"9","author":"Turner","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB64|cit64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-1746.1993.tb01189.x","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up","volume":"8","author":"Hwang","year":"1993","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB65|cit65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/BF02779195","article-title":"A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirhosis","volume":"25","author":"Oka","year":"1990","journal-title":"Gastroenterologia Japonica"},{"key":"10.1002\/14651858.CD000551-BIB66|cit66","series-title":"XI International Bile Acid Meeting. Bile Acids as Therapeutic Agents - From Basic Science to Clinical Practice. Freiburg","first-page":"76","article-title":"A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis in Japan","author":"Toda","year":"1990"},{"key":"10.1002\/14651858.CD000551-BIB74|cit67","first-page":"438 A","article-title":"Ursodeoxycholic acid therapy effects on pruritus and fatigue in primary biliary cirrhosis","volume":"26","author":"Ghent","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB70|cit68","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB72|cit69","series-title":"XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel. Falk Symposium No. 68","first-page":"45","article-title":"A double blind randomized controlled multi-centre trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC): results from a blinded interim analysis","author":"Heathcote","year":"1992"},{"key":"10.1002\/14651858.CD000551-BIB68|cit70","first-page":"91A","article-title":"The Canadian multi-centre double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis [AASLD abstract]","volume":"16","author":"Heathcote","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB71|cit71","first-page":"A914","article-title":"A four-year follow-up study of ursodeoxycholic acid therapy for primary biliary cirrhosis","volume":"104","author":"Heathcote","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB69|cit72","series-title":"Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Falk Symposium 68","first-page":"294","article-title":"A double-blind randomized controlled multicentre trial of ursodeoxycholic acid in primary biliary cirrhosis: results from a 1991 interim analysis","author":"Heathcote","year":"1993"},{"key":"10.1002\/14651858.CD000551-BIB67|cit73","first-page":"1148","article-title":"Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?","volume":"23","author":"Kilmurry","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB73|cit74","series-title":"XV International Bile Acid Meeting. Bile Acids and Cholestasis. Titisee, Germany. Falk Symposium No 108","first-page":"59","article-title":"Ursodeoxycholic acid reduces fibrosis in primary biliary cirrhosis (Abstract)","author":"Neuman","year":"1998"},{"key":"10.1002\/14651858.CD000551-BIB85|cit75","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/0300-9084(91)90098-L","article-title":"Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases","volume":"73","author":"Calmus","year":"1991","journal-title":"Biochimie"},{"key":"10.1002\/14651858.CD000551-BIB92|cit76","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","article-title":"The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis","volume":"32","author":"Corpechot","year":"2000","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB91|cit77","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.510290444","article-title":"Histopathologic study of primary biliary cirrhosis and the effect of ursodeoyxhcolic acid treatment on histological progression","volume":"29","author":"Degott","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB86|cit78","first-page":"202A","article-title":"Long term effect of ursodeoxycholic acid (UDCA) on hepatic function and portal hypertension in primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"20","author":"Huet","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB87|cit79","article-title":"Effects of ursodeoxycholic acid (UDCA) on hepatic function and portal hypertension in primary biliary cirrhosis (PBC)","volume":"118","author":"Huet","year":"1992","journal-title":"XII International Bile Acid Meeting. Bile Acids and the Hepatobiliary System. From Basic Science to Clinical Practice. Basel. Falk Symposium No. 68"},{"key":"10.1002\/14651858.CD000551-BIB84|cit80","first-page":"907","article-title":"Effects of ursodeoxycholic acid (UDCA) on hepatic function and portal hypertension in primary biliary cirrhosis (PBC) [AASLD abstract]","volume":"12","author":"Huet","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB90|cit81","series-title":"International Lugano Symposium on Biliary Physiology and Diseases: Strategies for the Treatment of Hepatobiliary Diseases. Lugano. Falk Symposium No. 53","first-page":"22","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Poupon","year":"1989"},{"key":"10.1002\/14651858.CD000551-BIB83|cit82","first-page":"79","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","author":"Poupon","year":"1990","journal-title":"Strategies for the Treatment of Hepatobiliary Diseases. Falk Symposium 53"},{"key":"10.1002\/14651858.CD000551-BIB89|cit83","series-title":"First International Symposium. Trends and Discovery in Bile Acid Research. Bora-Bora (French Polynesia)","first-page":"123","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","author":"Poupon","year":"1990"},{"issue":"6 Suppl 2","key":"10.1002\/14651858.CD000551-BIB93|cit84","first-page":"48","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"115","author":"Poupon","year":"1991","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000551-BIB76|cit85","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB78|cit86","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/hep.1840190314","article-title":"Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue","volume":"19","author":"Poupon","year":"1994","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB77|cit87","first-page":"872","article-title":"Beneficial effect of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC). Final results of the French Canadian trial [AASLD abstract]","volume":"12","author":"Poupon","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB75|cit88","first-page":"91A","article-title":"Ursodeoxycholic therapy for primary biliary cirrhosis: a four year controlled study","volume":"16","author":"Poupon","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB79|cit89","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840170412","article-title":"Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB80|cit90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0168-8278(90)90265-S","article-title":"Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group","volume":"11","author":"Poupon","year":"1990","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB81|cit91","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hep.1840170408","article-title":"Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB82|cit92","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group [see comments]","volume":"330","author":"Poupon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB88|cit93","first-page":"639","article-title":"Ursodeoxycholic acid (UDCA) for treatment of primary biliary cirrhosis (PBC). Interim analysis of a double-blind multicenter randomized trial","volume":"10","author":"Poupon","year":"1989","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD000551-BIB94|cit94","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB95|cit95","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"J Hepatol"},{"issue":"874","key":"10.1002\/14651858.CD000551-BIB96|cit96","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/pgmj.74.874.482","article-title":"Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival","volume":"74","author":"Bateson","year":"1998","journal-title":"Postgraduate Medical Journal"},{"issue":"7","key":"10.1002\/14651858.CD000551-BIB97|cit97","first-page":"215","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"136","author":"Brodanova","year":"1997","journal-title":"Casopis Lekaru Ceskych"},{"issue":"5","key":"10.1002\/14651858.CD000551-BIB98|cit98","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gut.43.5.705","article-title":"Fatigue in primary biliary cirrhosis","volume":"43","author":"Cauch-Dudek","year":"1998","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551-BIB99|cit99","first-page":"367","article-title":"Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis","volume":"146","author":"Crippa","year":"1995","journal-title":"Clin Ther"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB100|cit100","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/BF02213140","article-title":"Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study","volume":"41","author":"Crosignani","year":"1996","journal-title":"Digestive Diseases and Sciences"},{"issue":"34","key":"10.1002\/14651858.CD000551-BIB101|cit101","first-page":"695","article-title":"Treatment of primary biliary cirrhosis with ursodeoxycholic acid. Part 2: Prospective long-term trial in 21 patients","volume":"106","author":"Eisenburg","year":"1988","journal-title":"Fortschritte der Medizin"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB102|cit102","first-page":"321","article-title":"Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A controlled comparison with ursodeoxycholic acid","volume":"143","author":"Ferri","year":"1993","journal-title":"Clinica Terapeutica"},{"issue":"5","key":"10.1002\/14651858.CD000551-BIB103|cit103","first-page":"367","article-title":"Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis","volume":"146","author":"Crippa","year":"1995","journal-title":"Clinica Terapeutica"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB104|cit104","first-page":"62","article-title":"Efficacy of ursodeoxycholic acid in lowering alanine aminotransferase and gamma-glutamyl transpeptidase serum levels in patients with chronic active hepatitis and primary biliary cirrhosis","volume":"47","author":"Id\u00e9o","year":"1990","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB105|cit105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0168-8278(96)80191-7","article-title":"Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: A prospective randomized study","volume":"24","author":"Ikeda","year":"1996","journal-title":"Journal of Hepatology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD000551-BIB106|cit106","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/0168-8278(91)91511-E","article-title":"Effect of UDCA on the natural course of PBC","volume":"13","author":"Kehagioglou","year":"1991","journal-title":"J Hepatol"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB107|cit107","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","article-title":"Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation","volume":"26","author":"Kim","year":"1997","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB108|cit108","first-page":"11","article-title":"Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease","volume":"41","author":"Kneppelhout","year":"1992","journal-title":"Netherlands Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD000551-BIB109|cit109","first-page":"231","article-title":"Effects of ursodeoycholic acid treatment on bilirubin concentration and survival of patients with primary biliary cirrhosis","volume":"6","author":"Krzeski","year":"1999","journal-title":"Gastroenterol Pol (Gastroenterologia-Polska)"},{"issue":"2","key":"10.1002\/14651858.CD000551-BIB110|cit110","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.1365-2036.1997.124295000.x","article-title":"Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: A pilot crossover study","volume":"11","author":"Larghi","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB111|cit111","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8278(96)80327-8","article-title":"Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis","volume":"25","author":"Leuschner","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB112|cit112","series-title":"XV International Bile Acid Meeting. Bile Acids and Cholestasis. Falk Symposium No 108. Titisee, Germany","first-page":"62","article-title":"Determining the most efficacious dose of ursodeoxycholic acid in primary biliary cirrhosis (Abstract)","author":"Verma","year":"1998"},{"issue":"3","key":"10.1002\/14651858.CD000551-BIB113|cit113","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0168-8278(90)90134-D","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: No evidence for toxicity in the stages I to III","volume":"10","author":"Lotterer","year":"1990","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB114|cit114","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004836-199401000-00010","article-title":"Biochemical and histological changes after more than four years of treatment of ursodeoxycholic acid in primary biliary cirrhosis","volume":"18","author":"Matsuzaki","year":"1994","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD000551-BIB115|cit115","first-page":"15","article-title":"Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis","volume":"85","author":"Matsuzaki","year":"1990","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB116|cit116","first-page":"438 A","article-title":"Comparison of three different doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial","volume":"26","author":"Lindor","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB118|cit117","first-page":"1221 (A)","article-title":"Ursodeoxycholic acid improves liver function and reduces serum and urinary endogenous bile acids in primary biliary cirrhosis","volume":"8","author":"Batta","year":"1988","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB120|cit118","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0022-2275(20)38207-9","article-title":"Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment","volume":"30","author":"Batta","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1002\/14651858.CD000551-BIB119|cit119","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.1840100404","article-title":"Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis","volume":"10","author":"Batta","year":"1989","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB117|cit120","first-page":"1065 (A)","article-title":"Ursodeoxycholic acid treatment of primary biliary cirrhosis","volume":"83","author":"Eskreis","year":"1988","journal-title":"Am J Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB121|cit121","first-page":"691","article-title":"Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis","volume":"88","author":"Batta","year":"1993","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB122|cit122","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2957\/kanzo.34.306","article-title":"Effect of urosodeoxycholic acid therapy on lymphocyte function of patients with primary biliary cirrhosis","volume":"34","author":"Ogino","year":"1993","journal-title":"Acta Hepatologica Japonica"},{"issue":"6","key":"10.1002\/14651858.CD000551-BIB123|cit123","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2957\/kanzo.29.799","article-title":"A case of primary biliary cirrhosis - 4 years' treatment with 300 mg\/day ursodeoxycholic acid","volume":"29","author":"Okuyama","year":"1988","journal-title":"Acta Hepatologica Japonica"},{"issue":"12 SUPPL.","key":"10.1002\/14651858.CD000551-BIB124|cit124","doi-asserted-by":"crossref","first-page":"49S","DOI":"10.1007\/BF01536663","article-title":"Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis","volume":"34","author":"Osuga","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0016-5085(92)90781-S","article-title":"Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy","volume":"102","author":"Perdigoto","year":"1992","journal-title":"Gastroenterology"},{"issue":"(SUPPL. 2)","key":"10.1002\/14651858.CD000551-BIB127|cit126","first-page":"S25","article-title":"Ursodeoxycholic acid for chronic liver diseases","volume":"10","author":"Podda","year":"1988","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"12 SUPPL.","key":"10.1002\/14651858.CD000551-BIB126|cit127","doi-asserted-by":"crossref","first-page":"59S","DOI":"10.1007\/BF01536665","article-title":"Effect of different doses of ursodeoxycholic acid in chronic liver disease","volume":"34","author":"Podda","year":"1989","journal-title":"Digestive Diseases and Sciences"},{"issue":"8537","key":"10.1002\/14651858.CD000551-BIB128|cit128","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000551-BIB129|cit129","first-page":"637","article-title":"Ursodeoxycholic acid improves histologic features and progression of primary biliary cirrhosis","author":"Poupon","year":"1989","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD000551-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.510240520","article-title":"A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis","volume":"24","author":"Poupon","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB131|cit131","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000201472","article-title":"Serial quantitative liver function tests in patients with primary biliary cirrhosis: A prospective long-term study","volume":"58","author":"Schonfeld","year":"1997","journal-title":"Digestion"},{"issue":"3","key":"10.1002\/14651858.CD000551-BIB132|cit132","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1440-1746.1992.tb00980.x","article-title":"Combination therapy with ursodeoxycholic acid and colchicine for primary biliary cirrhosis","volume":"7","author":"Shibata","year":"1992","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3 I","key":"10.1002\/14651858.CD000551-BIB133|cit133","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840120308","article-title":"Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis","volume":"12","author":"Stiehl","year":"1990","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD000551-BIB134|cit134","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00042737-199406000-00015","article-title":"Does cholestyramine reduce the efficacy of ursodeoxycholic acid in primary biliary cirrhosis?","volume":"6","author":"Taha","year":"1994","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB135|cit135","first-page":"376","article-title":"A case of primary biliary cirrhosis with a histological improvement after long-term therapy with ursodeoxycholic acid","volume":"45","author":"Takezaki","year":"1991","journal-title":"IRYO Japanese Journal of National Medical Services"},{"key":"10.1002\/14651858.CD000551-BIB136|cit136","first-page":"443","article-title":"Dose-dependency of effect of ursodeoxycholic acid on primary biliary cirrhosis: a randomised, double-blind controlled study","volume":"37","author":"Toda","year":"1998","journal-title":"KAN-TAN-SUI (Japan)"},{"key":"10.1002\/14651858.CD000551-BIB137|cit137","series-title":"XI International Bile Acid Meeting. Bile Acids as Therapeutic Agents - From Basic Science to Clinical Practice. Freiburg","first-page":"Abstract No. 77","article-title":"Effects of ursodeoxycholic acid on lymphocyte functions in primary biliary cirrhosis","author":"Unoura","year":"1990"},{"key":"10.1002\/14651858.CD000551-BIB138|cit138","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0168-8278(96)80293-5","article-title":"Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response","volume":"25","author":"Meeberg","year":"1996","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB139|cit139","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2036.1998.00395.x","article-title":"A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg\/kg or 20 mg\/kg. Dutch Multicentre PBC Study Group","volume":"12","author":"Hoogstraten","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1002\/14651858.CD000551-BIB140|cit140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00042737-199910000-00001","article-title":"Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"19","key":"10.1002\/14651858.CD000551-BIB141|cit141","first-page":"810","article-title":"Eosinophilia in primary biliary cirrhosis: Regression under therapy with ursodeoxycholic acid","volume":"124","author":"Wirth","year":"1994","journal-title":"Schweizerische Medizinische Wochenschrift"},{"issue":"15","key":"10.1002\/14651858.CD000551-BIB142|cit142","first-page":"750","article-title":"Subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"125","author":"Wirth","year":"1995","journal-title":"Schweizerische Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD000551-BIB143|cit143","first-page":"84","article-title":"Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis","volume":"44","author":"Wolfhagen","year":"1994","journal-title":"Neth J Med"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB144|cit144","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2957\/kanzo.33.348","article-title":"A patient with asymptomatic primary biliary cirrhosis associated with eosinophilic infiltration and peripheral eosinophilia improved by the administration of ursodeoxycholic acid","volume":"33","author":"Yamazaki","year":"1992","journal-title":"Acta Hepatologica Japonica"},{"issue":"3","key":"10.1002\/14651858.CD000551-BIB145|cit145","first-page":"516","article-title":"Eosinophilia in primary biliary cirrhosis","volume":"91","author":"Yamazaki","year":"1996","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD000551-BIB146|cit146","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2957\/kanzo.37.102","article-title":"Rapid improvement of intractable pruritus in a case with primary biliary cirrhosis by a combined therapy of ursoderoxycholate (UDCA) and cholestyramine (CS) - Serum bile acid analysis","volume":"37","author":"Yokomori","year":"1996","journal-title":"Acta Hepatologica Japonica"},{"issue":"10","key":"10.1002\/14651858.CD000551-BIB147|cit147","first-page":"970","article-title":"Therapeutic effect of ursodeoxycholic acid on early-stage primary biliary cirrhosis","volume":"90","author":"Kao","year":"1991","journal-title":"Journal of the Formosan Medical Association"},{"issue":"5","key":"10.1002\/14651858.CD000551-BIB148|cit148","first-page":"311","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis. Results of short and medium-term administration and differences between early and advanced stages","volume":"80","author":"Garcia Villarreal","year":"1991","journal-title":"Revista Espanola de Enfermedades Digestivas"},{"issue":"5","key":"10.1002\/14651858.CD000551-BIB149|cit149","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00005792-199409000-00005","article-title":"Primary biliary cirrhosis (classical article)","volume":"73","author":"Ahrens","year":"1994","journal-title":"Medicine-Baltimore"},{"key":"10.1002\/14651858.CD000551-BIB150|cit150","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep.510290301","article-title":"Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis","volume":"29","author":"Angulo","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB151|cit151","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0168-8278(99)80136-6","article-title":"Comparison of three doses of ursodeoxycholic acid in the treatment of primmary biliary cirrhosis: a randomized trial","volume":"30","author":"Angulo","year":"1999","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB152|cit152","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0140-6736(00)02039-0","article-title":"Subgroup analysis and other (mis)uses of baseline data in clinical trials","volume":"355","author":"Assmann","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000551-BIB153|cit153","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB154|cit154","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(84)91108-5","article-title":"Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis","volume":"ii","author":"Ballardini","year":"1984","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000551-BIB155|cit155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0016-5085(85)90325-7","article-title":"Asymptomatic primary biliary cirrhosis: a progress report on long-term follow-up and natural history","volume":"89","author":"Beswick","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB156|cit156","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0016-5085(88)90300-9","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis","volume":"95","author":"Bodenheimer","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB157|cit157","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.510290140","article-title":"Clinical significance of serum bilirubin levels under ursodeoxyhcolic acid therapy in patients iwth primary biliary cirrhosis","volume":"29","author":"Bonnand","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB158|cit158","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"1","author":"Calmus","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB159|cit159","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/gut.30.8.1110","article-title":"Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment","volume":"30","author":"Chretien","year":"1989","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551-BIB160|cit160","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","article-title":"Clinical pattern and course of disease in primary biliary cirrhosis based on the analysis of 236 patients","volume":"78","author":"Christensen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB161|cit161","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB162|cit162","first-page":"1447","article-title":"Ursodeoxycholic acid in the treatment of chronic liver disease","volume":"89","author":"Cirillo","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB163|cit163","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/hep.510300315","article-title":"The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis","volume":"30","author":"Combes","year":"1999","journal-title":"Hepatolgy"},{"key":"10.1002\/14651858.CD000551-BIB164|cit164","first-page":"420","article-title":"Die Wirkung von Ursodeoxychols\u00e4ure bei chronischen Lebererkrankungen: eine Pilotstudie [abstract]","volume":"23","author":"David","year":"1985","journal-title":"Z Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB165|cit165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods of combining randomized clinical trials: strengths and limitations","volume":"6","author":"DeMets","year":"1987","journal-title":"Stat Med"},{"key":"10.1002\/14651858.CD000551-BIB166|cit166","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clin Trials"},{"key":"10.1002\/14651858.CD000551-BIB167|cit167","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM198504183121602","article-title":"Trial of penicillamine in advanced primary biliary cirrhosis","volume":"312","author":"Dickson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB168|cit168","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0016-5085(80)90078-5","article-title":"Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport","volume":"79","author":"Dumont","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB169|cit169","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"8233","key":"10.1002\/14651858.CD000551-BIB170|cit170","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(81)92456-9","article-title":"D-penicillamine treatment improves survival in primary biliary cirrhosis","volume":"1","author":"Epstein","year":"1981","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD000551-BIB171|cit171","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0016-5085(82)80125-X","article-title":"The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"83","author":"Epstein","year":"1982","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB172|cit172","first-page":"83","article-title":"Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) - a Cochrane Hepato-Biliary Systematic review","volume":"30","author":"Gluud","year":"1999","journal-title":"J Hepatol"},{"issue":"5","key":"10.1002\/14651858.CD000551-BIB173|cit173","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(01)00061-7","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis - lessons for the future","volume":"34","author":"Gluud","year":"2001","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB174|cit174","first-page":"57","article-title":"No evidence for ursodeoxycholic acid (UDCA) therapy in primary biliary cirrhosis (PBC): a meta-analysis (Abstact)","volume":"30","author":"Goulis","year":"1999","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB175|cit175","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD000551-BIB176|cit176","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/030006059001800608","article-title":"Treatment of chronic liver disease with ursodeoxycholic acid","volume":"18","author":"Guslandi","year":"1990","journal-title":"J Internat Med Res"},{"key":"10.1002\/14651858.CD000551-BIB177|cit177","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0016-5085(76)80250-8","article-title":"A prospective controlled trial of azathioprine in primary biliary cirrhosis","volume":"70","author":"Heathcote","year":"1976","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB178|cit178","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/he.2000.5984","article-title":"Management of primary biliary cirrhosis","volume":"31","author":"Heathcote","year":"2000","journal-title":"hepatology"},{"key":"10.1002\/14651858.CD000551-BIB179|cit179","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(87)92421-4","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"ii","author":"Hofmann","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000551-BIB180|cit180","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0016-5085(86)90183-6","article-title":"Randomized trial of chlorambucil for primary biliary cirrhosis","volume":"91","author":"Hoofnagle","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB181|cit181","series-title":"8th International Cochrane Colloquium, October","first-page":"21","article-title":"What certainty can there be on how much treatment work? Empirical insight from recursive cumulative meta-analyses (Abstract)","author":"Ioannidis","year":"2000"},{"key":"10.1002\/14651858.CD000551-BIB182|cit182","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1002\/14651858.CD000551-BIB183|cit183","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB184|cit184","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliaary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB185|cit185","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199405123301912","article-title":"Primary biliary cirrhosis - a first step in prolonging survival","volume":"330","author":"Kaplan","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB186|cit186","series-title":"Cochrane Collaboration Colloquium","first-page":"??","article-title":"Quality of randomised clinical trials affects estimates of intervention efficacy (abstract)","author":"Kjaergard","year":"1999"},{"issue":"11","key":"10.1002\/14651858.CD000551-BIB187|cit187","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodological quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000551-BIB188|cit188","first-page":"1834","article-title":"Gallstone dissolution in patients with chronic active hepatitis [abstract]","volume":"80","author":"Leuschner","year":"1981","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD000551-BIB189|cit189","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF01308413","article-title":"Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study","volume":"30","author":"Leuschner","year":"1985","journal-title":"Dig Dis Sci"},{"key":"10.1002\/14651858.CD000551-BIB190|cit190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/00365529409103624","article-title":"Ursodeoxycholic acid therapy in primary biliary cirrhosis","volume":"29 Suppl 204","author":"Leuschner","year":"1994","journal-title":"Scand J Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB191|cit191","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/gut.37.3.301","article-title":"The ursodeoxycholic acid story in primary biliary cirrhosis","volume":"37","author":"Lim","year":"1995","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551-BIB192|cit192","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB193|cit193","first-page":"31","article-title":"Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease","volume":"24","author":"Lirussi","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"10.1002\/14651858.CD000551-BIB194|cit194","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7326\/0003-4819-30-1-121","article-title":"Xanthomatous biliary cirrhosis (a clinical syndrome)","volume":"30","author":"MacMahon","year":"1949","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1002\/14651858.CD000551-BIB195|cit195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM198202113060602","article-title":"A prospective trial of D-penicillamine in primary biliary cirrhosis","volume":"306","author":"Matloff","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB196|cit196","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB197|cit197","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000551-BIB198|cit198","first-page":"25","article-title":"Some cases of gallstones dissolved by bile acid preparations","volume":"70","author":"Nakamo","year":"1973","journal-title":"J Nat Counc Communal Hosp"},{"issue":"2","key":"10.1002\/14651858.CD000551-BIB199|cit199","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.26.2.114","article-title":"Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis","volume":"26","author":"Neuberger","year":"1985","journal-title":"Gut"},{"key":"10.1002\/14651858.CD000551-BIB200|cit200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD000551-BIB201|cit201","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-1007193","article-title":"Survival algorithms and outcome analysis in primary biliary cirrhosis","volume":"17","author":"Pasha","year":"1997","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD000551-BIB202|cit202","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/hep.510290116","article-title":"Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis","volume":"29","author":"Pasha","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB203|cit203","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"i","author":"Poupon","year":"1987","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000551-BIB204|cit204","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840170412","article-title":"Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy","volume":"17","author":"Poupon","year":"1993","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB205|cit205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0163-7258(94)00073-C","article-title":"Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children","volume":"66","author":"Poupon","year":"1995","journal-title":"Pharmac Ther"},{"key":"10.1002\/14651858.CD000551-BIB206|cit206","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0016-5085(97)70183-5","article-title":"Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis","volume":"113","author":"Poupon","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB207|cit207","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0168-8278(00)80232-9","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past - issues for the future","volume":"32","author":"Poupon","year":"2000","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB208|cit208","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0168-8278(01)81676-7","article-title":"Long-term survival in 'modern' PBC is significantly better than the Mayo Model predicts","volume":"34","author":"Prince","year":"2001","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB209|cit209","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM198702193160806","article-title":"Meta-analysis of randomised controlled trials","volume":"19","author":"Sacks","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB210|cit210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methdological quality associated with estimates of treatment in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000551-BIB211|cit211","first-page":"392","article-title":"Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis","volume":"89","author":"Simko","year":"1994","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1002\/14651858.CD000551-BIB212|cit212","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0168-8278(86)80483-4","article-title":"Expression of MHC products by normal and abnormal bile duct epithelium","volume":"3","author":"Oord","year":"1986","journal-title":"J Hepatol"},{"key":"10.1002\/14651858.CD000551-BIB213|cit213","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00042737-199910000-00001","article-title":"Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis","volume":"11","author":"Verma","year":"1999","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB214|cit214","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid [see comments]","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD000551-BIB215|cit215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis: trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"J Hepatol"},{"issue":"20","key":"10.1002\/14651858.CD000551-BIB216|cit216","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD000551-BIB217|cit217","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0168-8278(98)80254-7","article-title":"Triple therapy iwth ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomised placebo-controlled study","volume":"29","author":"Wolfhagen","year":"1998","journal-title":"J Hepatol"},{"issue":"3","key":"10.1002\/14651858.CD000551-BIB218|cit218","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/hep.1840060309","article-title":"Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis","volume":"6","author":"Yamada","year":"1986","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD000551-BIB219|cit219","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.1991.03470010097038","article-title":"Analysis and interpretation of treatment effects in subgroups of patients in randomised clinical trials","volume":"266","author":"Yusuf","year":"1991","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD000551-BIB220|cit220","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1572-0241.1998.00287.x","article-title":"Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy","volume":"93","author":"Zukowski","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1002\/14651858.CD000551-BIB221|cit221","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis (Protocol)","author":"Christensen","year":"1997","journal-title":"The Cochrane Library"},{"issue":"2","key":"10.1002\/14651858.CD000551-BIB222|cit222","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis (Updated protocol)","author":"Gluud","year":"1999","journal-title":"The Cochrane Library"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD000551-BIB223|cit223","first-page":"83 (Abstract)","article-title":"Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC) - a Cochrane Hepato-Biliary systematic review","volume":"30","author":"Gluud","year":"1999","journal-title":"J Hepatol"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD000551","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T16:58:17Z","timestamp":1628528297000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000551"}},"subtitle":[],"editor":[{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2001,10,23]]},"references-count":223,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000551","relation":{},"subject":[],"published":{"date-parts":[[2001,10,23]]}}}